Heron Therapeutics | HRTX - 销售毛利

金融业

USD

USD 246.22M

现金及等价物

USD 26.12M

USD 11.12M

USD 228.98M

USD 90.52M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 9.14M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 134.1M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.97M

应收帐款人

USD 89.59M

	销售毛利	更改		日
ALKERMES	USD 331.33M		7M	2026-03
Alnylam Pharmaceuticals	USD 825M		4.3M	2026-03
Amarin	USD 23.17M		961K	2025-12
ANI Pharmaceuticals	USD 124.18M		12.39M	2025-12
Anika Therapeutics	USD 19.18M		3.6M	2025-12
Arrowhead Research	USD 264.03M		7.56M	2025-12
Eisai	JPY 153.41B		15.44B	2026-03
Esperion Therapeutics	USD 140.59M		94.57M	2025-12
GlaxoSmithKline	GBP 5.75B		429M	2026-03
Heron Therapeutics	USD 29.47M		3.17M	2025-12
Insmed	USD 256.46M		38.78M	2026-03
Ligand Pharmaceuticals	USD 48.45M		8.22M	2026-03
Merck	USD 10.85B		2.57B	2025-12
Nektar Therapeutics	USD 21.81M		8.06M	2025-12
Neurocrine Biosciences	USD 800.7M		12.8M	2026-03
Omeros	USD -33.16M		18.52M	2024-06
Pacira	USD 126.64M		15.61M	2026-03
Regeneron Pharmaceuticals	USD 2.94B		363.7M	2026-03
Roche Holding	CHF 22.09B		10.04B	2025-12
Sangamo BioSciences	-2.39M		1.09M	2024-06
Surmodics	USD 20.08M		31.62M	2025-06
Ultragenyx Pharmaceutical	USD 106M		72M	2026-03
Veracyte	USD 101.16M		814K	2026-03
Vertex Pharmaceuticals	USD 2.6B		121.7M	2026-03